Skip to main content

Many of the drug classes which are included in the prior authorization program are reviewed each fiscal year.  These reports include detailed statistics on utilization, prior authorization, market share, new products, and other notable events for the category during the previous year.  These reports were not included on a DUR Board agenda and are in addition to the utilization reports included with the DUR Board packets.

 

2009

Amitiza 

Antihistamines 

Antihypertensives

Bladder Control

Brovana 

Elidel Protopic 

FAD 

Forteo 

Glaucoma 

Glumetza and Fortamet 

Muscle Relaxants 

Nasal Allergy

Ocular Allergy 

Qualaquin 

Smoking Cessation 

Symlim 

Xolair 

 

Last Modified on Nov 10, 2020
Back to Top
Back to top

Oklahoma Health Care Authority

4345 N Lincoln Blvd

Oklahoma City, OK 73105

Contact Us

The Oklahoma Health Care Authority collects the personally identifiable data submitted and received in regard to applications for services, renewals, appeals, provision of health care and processing of claims. This data is treated as confidential and is stored securely in accordance with applicable law and regulations. OHCA may share this personally identifiable data with its authorized business associates, government agencies with jurisdiction over the OHCA, or as otherwise required or permitted by applicable law.